NDC 51167-331

Trikafta

Elexacaftor, Tezacaftor, And Ivacaftor

Trikafta is a Kit in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is .

Product ID51167-331_12edff26-ed48-49e6-b1b8-887447e6eac3
NDC51167-331
Product TypeHuman Prescription Drug
Proprietary NameTrikafta
Generic NameElexacaftor, Tezacaftor, And Ivacaftor
Dosage FormKit
Marketing Start Date2019-10-21
Marketing CategoryNDA / NDA
Application NumberNDA212273
Labeler NameVertex Pharmaceuticals Incorporated
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51167-331-01

4 BLISTER PACK in 1 CARTON (51167-331-01) > 1 KIT in 1 BLISTER PACK * 14 TABLET, FILM COATED in 1 BLISTER PACK * 7 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2019-10-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51167-331-01 [51167033101]

Trikafta KIT
Marketing CategoryNDA
Application NumberNDA212273
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-10-21

Drug Details

NDC Crossover Matching brand name "Trikafta" or generic name "Elexacaftor, Tezacaftor, And Ivacaftor"

NDCBrand NameGeneric Name
51167-106TrikaftaElexacaftor, Tezacaftor, and Ivacaftor
51167-331TrikaftaElexacaftor, Tezacaftor, and Ivacaftor

Trademark Results [Trikafta]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRIKAFTA
TRIKAFTA
88031776 not registered Live/Pending
Vertex Pharmaceuticals Incorporated
2018-07-10
TRIKAFTA
TRIKAFTA
87924202 5938974 Live/Registered
Vertex Pharmaceuticals Incorporated
2018-05-16
TRIKAFTA
TRIKAFTA
87893193 5938914 Live/Registered
Vertex Pharmaceuticals Incorporated
2018-04-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.